Reasons To Own AbbVie After Abbott Splits In Two – Seeking Alpha
Reasons To Own AbbVie After Abbott Splits In TwoSeeking AlphaAbbott also expects Phase III results for Daclizumab in 2014. The drug is used to treat multiple sclerosis, an inflammatory disease affecting the nervous system affecting an estimated 2.1 mil…